Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. - Lampe JW; Alford JS; Boriak-Sjodin PA; Brach D; Cosmopoulos K; Duncan KW; Eckley ST; Foley MA; Harvey DM; Motwani V; Munchhof MJ; Raimondi A; et al. (ACS medicinal chemistry letters, 2021)